RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

Add to Collection
2009 Apr Observational studies Fist_Author_Year_PM

Full Author : ['Shah, S', 'Benroubi, M', 'Borzi, V', 'Gumprecht, J', 'Kawamori, R', 'Shaban, J', 'Shestakova, M', 'Wenying, Y', 'Valensi, P']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2009
Cited by : Not Available

AIMS: IMPROVE is an open-label, multinational, non-randomised, 26-week observational study designed to evaluate the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in routine clinical practice. Here, we report data for patients switching.....

Keywords : ["type diabetes subgroup analysis", "biphasic insulin aspart novomix", "human premix insulin", "improve observational study", "switch", "safety", "patient", "effectiveness"]